160 related articles for article (PubMed ID: 16214922)
1. Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk.
Skibola CF; Bracci PM; Paynter RA; Forrest MS; Agana L; Woodage T; Guegler K; Smith MT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2391-401. PubMed ID: 16214922
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma.
Skibola CF; Lightfoot T; Agana L; Smith A; Rollinson S; Kao A; Adamson P; Morgan GJ; Smith MT; Roman E
Br J Haematol; 2005 Jun; 129(5):618-21. PubMed ID: 15916684
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17α in preeclampsia.
Lim JH; Kim SY; Kim DJ; Park SY; Han HW; Han JY; Lee SW; Yang JH; Ryu HM
Pharmacogenet Genomics; 2010 Oct; 20(10):605-10. PubMed ID: 20729792
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland.
Campbell PT; Edwards L; McLaughlin JR; Green J; Younghusband HB; Woods MO
Clin Cancer Res; 2007 Jul; 13(13):3783-8. PubMed ID: 17606708
[TBL] [Abstract][Full Text] [Related]
5. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas.
Denschlag D; Bentz EK; Hefler L; Pietrowski D; Zeillinger R; Tempfer C; Tong D
Fertil Steril; 2006 Feb; 85(2):462-7. PubMed ID: 16595228
[TBL] [Abstract][Full Text] [Related]
6. Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.
Zhang Y; Hua S; Zhang A; Kong X; Jiang C; Deng D; Wenlong B
Clin Lung Cancer; 2013 Jan; 14(1):45-9. PubMed ID: 22658813
[TBL] [Abstract][Full Text] [Related]
7. Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction.
Sata F; Yamada H; Suzuki K; Saijo Y; Yamada T; Minakami H; Kishi R
Pharmacogenet Genomics; 2006 Nov; 16(11):775-81. PubMed ID: 17047485
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
9. EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients.
Yang SY; Yang TY; Chen KC; Li YJ; Hsu KH; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Shen CY; Chang GC; Yang PC; Chen CJ
Clin Cancer Res; 2011 Apr; 17(8):2149-58. PubMed ID: 21300759
[TBL] [Abstract][Full Text] [Related]
10. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.
Garner EI; Stokes EE; Berkowitz RS; Mok SC; Cramer DW
Cancer Res; 2002 Jun; 62(11):3058-62. PubMed ID: 12036914
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in CYP17, COMT, and ESR1 genes in women after menopause and association with bone mineral density.
Gonçalves CG; Almeida BC; Camargo-Kosugi CM; Costa AM; Silva ID; Haidar MA
Genet Mol Res; 2015 Dec; 14(4):15802-10. PubMed ID: 26634548
[TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.
Gaudet MM; Bensen JT; Schroeder J; Olshan AF; Terry MB; Eng SM; Teitelbaum SL; Britton JA; Lehman TA; Neugut AI; Ambrosone CB; Santella RM; Gammon MD
Breast Cancer Res Treat; 2006 Sep; 99(2):235-40. PubMed ID: 16596327
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.
Duell EJ; Holly EA; Kelsey KT; Bracci PM
Int J Cancer; 2010 Feb; 126(3):790-5. PubMed ID: 19642097
[TBL] [Abstract][Full Text] [Related]
17. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R
Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
[TBL] [Abstract][Full Text] [Related]
20. Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.
Tofteng CL; Abrahamsen B; Jensen JE; Petersen S; Teilmann J; Kindmark A; Vestergaard P; Gram J; Langdahl BL; Mosekilde L
Calcif Tissue Int; 2004 Aug; 75(2):123-32. PubMed ID: 15129369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
